Improving Therapeutic Vaccination against Hepatitis B—Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection

Chronic hepatitis B affects more than 250 million individuals worldwide, putting them at risk of developing liver cirrhosis and liver cancer. While antiviral immune responses are key to eliminating hepatitis B virus (HBV) infections, insufficient antiviral immunity characterized by failure to elimin...

Descripción completa

Detalles Bibliográficos
Autores principales: Knolle, Percy A., Huang, Li-Rung, Kosinska, Anna, Wohlleber, Dirk, Protzer, Ulrike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623083/
https://www.ncbi.nlm.nih.gov/pubmed/34835264
http://dx.doi.org/10.3390/vaccines9111333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623083/
https://www.ncbi.nlm.nih.gov/pubmed/34835264
http://dx.doi.org/10.3390/vaccines9111333

Ejemplares similares